#390 ‒ AMA #84: Family health history, preventing heart disease, metabolic health, strength training efficiency, dementia risk reduction, NAD supplements, and hydration

Peter Attia

May 4, 2026

Episode description

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

In this "Ask Me Anything" (AMA) episode, Peter answers listener questions across a wide range of topics, focusing on how to think through real-world trade-offs and apply scientific evidence in practice. He explores how to build and interpret a meaningful family health history, how individual risk tolerance influences decisions around testing and treatment, and why heart disease remains poorly prevented despite available tools. He also examines whether it's possible to carry excess body fat while remaining metabolically healthy, outlines the minimum effective dose for strength training for those with limited time, and discusses the habits and interventions most likely to reduce dementia risk. Additional topics include what evidence would need to emerge for him to reconsider his current stance on NAD-boosting supplements, and when hydration and electrolyte strategies are truly beneficial versus unnecessary.

If you're not a subscriber and are listening on a podcast player, you'll only be able to hear a preview of the AMA. If you're a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #84 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

We discuss:

Topics overview [1:15];
Using family history to assess disease risk: why it matters more than genetic testing and how to analyze it effectively [2:30];
Peter's views that differ from conventional medicine: approaches to cardiovascular risk, cancer screening, nutrition, and more [10:30];
Risk tolerance in health decisions: weighing action versus inaction and avoiding low-benefit, high-risk interventions [16:00];
Why cardiovascular disease persists: delayed treatment, insufficient thresholds, and missed opportuni

Mindsip insights from this episode:

Examine metabolic health in individuals with excess body fat

The podcast explores the question of whether a person can carry excess body fat and still be considered metabolically healthy.

#metabolism

#obesity

Observe family health outcomes to understand gene expression risks

Even if you have a gene for a condition, it may not express itself due to varying 'degrees of penetration,' which is why observing actual health outcomes in your family is so important.

#genetics

Prioritize family history over genetic tests for disease risk

A thorough family history is often more valuable than genetic testing for common diseases like heart disease or cancer because these conditions are typically polygenic, meaning they arise from many genes, not a single one.

#cancer

#genetics

Challenge skepticism on NAD boosters with evidence

The speaker plans to outline what specific evidence would be needed to change his current skeptical viewpoint on NAD-boosting supplements like NR and NMN.

#NAD

#supplement

Identify critical hydration needs versus electrolyte overkill

The speaker will discuss when hydration and electrolytes are critical versus when they are mostly unnecessary or overkill.

#electrolyte

#hydration

Prioritize minimum effective dose for strength training benefits

For busy people, there is a 'minimum effective dose' for strength training that can be prioritized to still achieve significant benefits.

#efficiency

#strength

Peter Attia

#399 ‒ The evolution of Alzheimer's disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.

Building strength and muscle mass: how to optimize training, nutrition, and more for longevity (AMA #71 rebroadcast)

#398 ‒ AMA #86: GLP-1 RAs and muscle loss: new data, better questions, and how to preserve muscle during weight loss

#397 ‒ Endometriosis and adenomyosis: diagnosis, fertility, reproductive aging, and emerging treatments | Renato Tomioka, M.D., Ph.D.

#396 ‒ Breast cancer screening: understanding risk, deciding when to start and how often to screen, and choosing the right imaging strategy